Drug Shortage Report for ODAN PROCTOMYXIN HC
Report ID | 136515 |
Drug Identification Number | 02242527 |
Brand name | SANDOZ PROCTOMYXIN HC |
Common or Proper name | SANDOZ PROCTOMYXIN HC |
Company Name | ODAN LABORATORIES LTD |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCORTISONE DIBUCAINE HYDROCHLORIDE FRAMYCETIN SULFATE ESCULIN |
Strength(s) | 0.5% 0.5% 1% 1% |
Dosage form(s) | OINTMENT |
Route of administration | RECTAL RECTAL |
Packaging size | 30g OIN CA |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-03-26 |
Estimated end date | Unknown |
Actual end date | 2021-08-05 |
Shortage status | Resolved |
Updated date | 2021-08-06 |
Company comments | product discontinued |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-08-06 | English | Compare |
v4 | 2021-08-05 | French | Compare |
v3 | 2021-08-05 | English | Compare |
v2 | 2021-03-29 | French | Compare |
v1 | 2021-03-29 | English | Compare |
Showing 1 to 5 of 5